Financial Gravity Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.5K Hold
182
﹤0.01% 480
2025
Q4
$16.4K Hold
182
﹤0.01% 410
2025
Q3
$17.9K Buy
+182
New +$18K ﹤0.01% 449
2025
Q1
$20.6K Buy
+182
New +$19.5K ﹤0.01% 473
2024
Q2
Sell
-2
Closed -$274 1816
2024
Q1
$274 Hold
2
﹤0.01% 917
2023
Q4
$418 Buy
+2
New +$223 ﹤0.01% 908
2019
Q2
Sell
-106
Closed -$13K 1708
2019
Q1
$13K Buy
+106
New +$12K 0.01% 517
2018
Q3
$0 Sell
2
-389
-99% -$46.3K ﹤0.01% 1651
2018
Q2
$47K Buy
391
+307
+365% +$33.4K 0.04% 348
2018
Q1
$10K Buy
+84
New +$9.76K 0.01% 593

Other funds holding ZBH

Financial Gravity Asset Management's ZBH Position: Q1 2026 in Review

Financial Gravity Asset Management held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 182 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

Financial Gravity Asset Management first reported a position in ZBH in Q1 2018 and has held it in 10 quarters since. The position peaked at $47K in Q2 2018. 918 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Financial Gravity Asset Management held 182 shares of Zimmer Biomet worth $16.5K as of Q1 2026.
  • Financial Gravity Asset Management left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q1 2026, its #480 holding.
  • Financial Gravity Asset Management first reported a position in Zimmer Biomet in Q1 2018 and has held it in 10 quarters since.
  • Financial Gravity Asset Management's Zimmer Biomet position peaked at $47K in Q2 2018.
  • 918 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.